When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Leukemia & Lymphoma Society - Wikipedia

   en.wikipedia.org/wiki/Leukemia_&_Lymphoma_Society

   The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. LLS funds blood cancer research on cures for leukemia, lymphoma, Hodgkin's disease, and myeloma. It provides free information and support services, and it advocates for ...

3. Phi Sigma Rho - Wikipedia

   en.wikipedia.org/wiki/Phi_Sigma_Rho

   Phi Sigma Rho's national philanthropy is the Leukemia & Lymphoma Society. [6] The Phi Sigma Rho Foundation was established as a separate nonprofit organization in 2005. [6] It supports the educational and philanthropic efforts of the sorority's members and offers merit-based scholarships to sorority members. [6] [7]

4. Lymphoma - Wikipedia

   en.wikipedia.org/wiki/Lymphoma

   Lymphoma is a group of blood and lymph tumors that develop from lymphocytes (a type of white blood cell). [7] ... According to the U.S. National Institutes of Health, ...

5. 5 Things You Should Know About DLBCL, the Most Common ... - AOL

   www.aol.com/5-things-know-dlbcl-most-130022299.html

   Non-Hodgkin’s lymphoma (NHL) is one of the most common forms of blood cancer.1 The American Cancer Society estimates that about 81,560 people in the U.S. will be diagnosed with NHL and about ...

6. Team In Training - Wikipedia

   en.wikipedia.org/wiki/Team_In_Training

   Team In Training. Team In Training (TNT) is the flagship fundraising program for the Leukemia & Lymphoma Society (LLS), the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.

7. Jonathan D. Licht - Wikipedia

   en.wikipedia.org/wiki/Jonathan_D._Licht

   Licht’s cancer career spans nearly three decades, and his research program covers over 30 years of continuous NCI and national foundation funding. Licht leads a Specialized Center of Research program from the Leukemia and Lymphoma Society [7] and is principal investigator of three National Cancer Institute R01 grants. He has trained over a ...